A significant increase in adenosine deaminase levels has been demonstrated in various tumor tissues, including cholangiocarcinoma, lymphoma, diffuse large B-cell lymphoma, and pancreatic adenocarcinoma. This evidence concerns the gene ADA and neoplasm.